コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 /=25 mm/m(2)) in whom initial management was expectant.
2 ular function in whom initial management was expectant.
3 atients with cirrhosis should change from an expectant algorithm that treats complications as they oc
6 ggest that treating stress and depression in expectant and new mothers could reduce viral respiratory
7 ased data to investigate whether becoming an expectant and/or new father is associated with increases
8 sensory thalamocortical pathway of alert and expectant animals is in the adapted state, which may be
9 ment of dormant disease in which the current expectant approach is replaced with active attempts to u
12 en in the FETO group than among those in the expectant care group (44% vs. 12%; relative risk, 3.79;
13 en in the FETO group than among those in the expectant care group (47% vs. 11%; relative risk, 4.51;
14 FETO group (63%) and 49 of 98 infants in the expectant care group (50%) survived to discharge (relati
15 in the FETO group and 14% among those in the expectant care group (relative risk, 2.65; 95% CI, 1.21
16 harge, as compared with 15% (6 of 40) in the expectant care group (relative risk, 2.67; 95% confidenc
17 FETO group and 43 of 98 infants (44%) in the expectant care group were alive without oxygen supplemen
18 erformed at 30 to 32 weeks of gestation over expectant care with respect to survival to discharge or
19 ation resulted in a significant benefit over expectant care with respect to survival to discharge, an
26 ptumLabs Data Warehouse), we identified 7453 expectant fathers with IMIDs (inflammatory bowel disease
28 and/or biologic agents around conception in expectant fathers with immune-mediated inflammatory dise
34 ) with FAV versus 72% (95% CI, 61%-82%) with expectant fetal management, resulting in a restricted me
36 n the immediate birth group and three in the expectant group were excluded from the primary analyses.
37 weeks of gestation ("IOL group") compared to expectant management ("expectant management group") acco
39 as significantly lower with active than with expectant management (51 [6.8%] of 748 vs 126 [16.5%] of
41 our at 39, 40, and 41 weeks of gestation and expectant management (continuation of pregnancy to eithe
42 olled trial comparing pessary placement with expectant management (control) in girls and women who we
43 days and 39 weeks 6 days of gestation or to expectant management (i.e., waiting until the spontaneou
45 patients were randomized in a 1:1:1 ratio to expectant management (n = 86), active management with ut
46 Compared with patients randomized to receive expectant management (n = 86), women randomized to recei
47 trolled cord traction or maternal effort) or expectant management (no prophylactic oxytocic, no cord
48 (3%) of 912 neonates of mothers assigned to expectant management (relative risk [RR] 0.8, 95% CI 0.5
49 (7%) of 911 neonates of mothers assigned to expectant management (RR 1.2, 95% CI 0.9-1.6; p=0.32).
50 f neonatal or infant outcomes, compared with expectant management (usual care) in women with late pre
51 d Wales, we compared planned delivery versus expectant management (usual care) with individual random
54 days' and 39 weeks and 6 days' gestation vs expectant management and (2) birth via induction of labo
55 edictive nomograms continue to shed light on expectant management as an option for men with clinicall
60 ith an esophageal coin, current data support expectant management for a period of 12-24 h with the ho
61 cruited adults (aged 18-65 years) undergoing expectant management for a single ureteric stone identif
62 ressive disorder were more likely to undergo expectant management for low-, intermediate-, and high-r
63 nce failed to improve outcomes compared with expectant management for patients who were seemingly in
65 group (196 [42%] infants) compared with the expectant management group (159 [34%] infants; 1.26, 1.0
66 the IOL group (1 555/47 352) and 3.6% in the expectant management group (16 525/453 720) had an adver
67 delivery group (154 [55%]) compared with the expectant management group (168 [60%]; adjusted risk rat
68 ry group (289 [65%] women) compared with the expectant management group (338 [75%] women; adjusted re
69 delivery group (58 [19%]) compared with the expectant management group (67 [22%]; adjusted risk diff
70 PDA, death or BPD did not differ between the expectant management group and the active treatment grou
71 ediate delivery group, those assigned to the expectant management group had higher risks of antepartu
72 h occurred in 0.8% (2/241) of infants in the expectant management group vs 3.8% (9/240) of infants in
73 or BPD was 80.9% (195/241) of infants in the expectant management group vs 79.6% (191/240) of infants
74 rual age was 4.1% (10/241) of infants in the expectant management group vs 9.6% (23/240) of infants i
75 L group") compared to expectant management ("expectant management group") according to maternal chara
76 tervals (CIs)) between the IOL group and the expectant management group, adjusting for ethnicity, soc
83 and randomly assigned to planned delivery or expectant management in a 1:1 ratio by a secure web-base
85 d trial, we compared planned delivery versus expectant management in women with pre-eclampsia from 34
86 d odds of active (surgical or medication) vs expectant management included ED (vs outpatient) present
92 nosis of miscarriage, and be able to provide expectant management of miscarriage, medical management
93 nd caesarean delivery rates when compared to expectant management of pregnancy (allowing the pregnanc
95 f labor at 39 weeks' gestation compared with expectant management of singleton, nonanomalous, births
98 erage with three antibiotics was better than expectant management or one or two antibiotic approaches
101 2020 for RCTs comparing IOL at 41 weeks with expectant management until 42 weeks in women with uncomp
102 eks improved perinatal outcome compared with expectant management until 42 weeks without increasing t
104 f infection or fetal compromise, a policy of expectant management with appropriate surveillance of ma
106 duction of labour at 40 weeks (compared with expectant management) was associated with a lower risk o
109 their randomized allocation (26.7% declined expectant management, 48.3% declined uterine evacuation,
110 superiority of the active groups combined vs expectant management, and a secondary hypothesis tested
113 r at 39 weeks of gestation, as compared with expectant management, had no significant effect on the r
114 ) and longer-term consequences compared with expectant management, in a setting where both management
115 aternal and perinatal outcomes compared with expectant management, longer-term childhood developmenta
116 t, compared with those randomized to receive expectant management, more frequently achieved successfu
118 t fertility care and were advised to undergo expectant management, treatment with intrauterine insemi
119 bidity and severe hypertension compared with expectant management, with more neonatal unit admissions
129 tion group [32%] and 103 of 314 women in the expectant-management group [33%]; relative risk, 0.99; 9
130 occurred in 24 of 136 infants (17.6%) in the expectant-management group and in 21 of 137 (15.3%) in t
131 occurred in 63 of 136 infants (46.3%) in the expectant-management group and in 87 of 137 (63.5%) in t
133 ARTICIPANTS: The Lifestyle Interventions for Expectant Moms (LIFE-Moms) trial was a consortium of 7 i
134 In this report, we describe the case of an expectant mother who had a febrile illness with rash at
137 , and proper counseling should be offered to expectant mothers with regard to both the risks that pre
143 olated CN VI palsy, which allows for initial expectant observation and re-consideration of obtaining
144 therapy, multiple observations suggest that expectant observation could be a safe alternative for in
146 rtical transmission in these bats, which are expectant of reservoir hosts, but may also reveal an anc
147 e in psychological distress as a function of expectant or new fatherhood; instead, some improvement i
148 findings provide longer-run information for expectant parents and physicians who are considering del
152 Key inclusion criteria: studies reflecting expectant parents' views of the factors influencing thei
156 with localized prostate cancers followed by expectant (watchful waiting) therapy with 15% (17/111) T